Latest news with #ModivCare
Yahoo
11-05-2025
- Business
- Yahoo
ModivCare First Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$650.7m (down 4.9% from 1Q 2024). Net loss: US$50.4m (loss widened by 126% from 1Q 2024). US$3.52 loss per share (further deteriorated from US$1.57 loss in 1Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 129%. Looking ahead, revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are down 20% from a week ago. It is worth noting though that we have found 5 warning signs for ModivCare (1 is concerning!) that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Washington Post
08-05-2025
- Business
- Washington Post
ModivCare: Q1 Earnings Snapshot
DENVER — DENVER — ModivCare Inc. (MODV) on Thursday reported a loss of $50.4 million in its first quarter. The Denver-based company said it had a loss of $3.52 per share. Losses, adjusted for one-time gains and costs, were $1.71 per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
Associated Press
28-03-2025
- Business
- Associated Press
MODV FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ModivCare Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - March 28, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ModivCare Inc. (NASDAQ: MODV) between November 3, 2022 and September 15, 2024, both dates inclusive (the 'Class Period'), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased ModivCare securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the ModivCare class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements as well as failed to disclose adverse facts about ModivCare's business, operations, and prospects. Specifically, defendants failed to disclose that certain contracts used in ModivCare's non-emergency medical transportation ('NEMT') segment caused ModivCare's free cash flow to deteriorate and that, as a result: (i) contract renegotiations and pricing accommodations negatively impacted ModivCare's adjusted EBITDA; (ii) ModivCare had insufficient liquidity; and (iii) defendants' positive statements about ModivCare's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the ModivCare class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653
Associated Press
28-03-2025
- Business
- Associated Press
Deadline Soon: ModivCare, Inc. (MODV) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Mar 28, 2025-- The Law Offices of Frank R. Cruz reminds investors of the upcoming March 31, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired ModivCare, Inc. ('ModivCare' or the 'Company') (NASDAQ: MODV) securities between , inclusive (the 'Class Period'). What Happened? On May 4, 2023, ModivCare released its first quarter 2023 financial results, revealing that it had experienced a reduction of cash flow from operations. On this news, ModivCare's stock price fell $11.30, or 16.3%, to close at $58.00 per share on May 4, 2023, thereby injuring investors. Then, on August 3, 2023, after market hours, ModivCare released its second quarter 2023 financial report, disclosing that the Company had experienced the expansion of a 'large payable balance' that had impacted its cash flow from operations during the quarter. On this news, ModivCare's stock price fell $2.86, or 7.5%, to close at $35.38 per share on August 4, 2023. Then, on February 23, 2024, ModivCare released its fourth quarter 2023 financial results, revealing that the Company suffered negative cash flow during the quarter, and that the trend was expected to continue for the first half of fiscal year 2024. On this news, ModivCare's stock price fell $17.25, or 39.3%, to close at $26.62 per share on February 23, 2024. Then, on September 12, 2024, ModivCare disclosed that it would 'undertak[e] actions to seek additional capital, including filing a shelf registration statement' with the SEC to improve its liquidity. On this news, ModivCare's stock price fell $18.43, or 59.1%, to close at $12.76 per share on September 12, 2024. Then, on September 16, 2024, ModivCare provided a financial update, revising its 2024 Adjusted EBITDA guidance range from $185–$195 million to $170–$180 million, 'primarily due to NEMT segment pricing accommodations made to strategically retain and expand key customer relationships.' On this news, ModivCare's stock price fell $1.40, or 9.9%, to close at $12.72 per share on September 16, 2024, thereby injuring investors further. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) certain contracts used in ModivCare's NEMT segment caused the Company's free cash flow to deteriorate; (2) contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA; (3) the Company had insufficient liquidity; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired ModivCare securities between November 3, 2022 and September 15, 2024, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is March 31, 2025. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us: Frank R. Cruz The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007 If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Frank R. Cruz, 310-914-5007 SOURCE: The Law Offices of Frank R. Cruz Copyright Business Wire 2025. PUB: 03/28/2025 12:28 PM/DISC: 03/28/2025 12:27 PM
Associated Press
28-03-2025
- Business
- Associated Press
MODV Deadline: Rosen Law Firm Urges ModivCare Inc. (NASDAQ: MODV) Stockholders with Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of securities of ModivCare Inc. (NASDAQ: MODV) between November 3, 2022 and September 15, 2024. ModivCare describes itself as a company that 'provides a suite of integrated supportive care solutions for public and private payors and their members[.]' For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that ModivCare Inc. (NASDAQ: MODV) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements as well as failed to disclose adverse facts about ModivCare's business, operations, and prospects. Specifically, defendants failed to disclose that certain contracts used in ModivCare's non-emergency medical transportation ('NEMT') segment caused ModivCare's free cash flow to deteriorate and that, as a result: (i) contract renegotiations and pricing accommodations negatively impacted ModivCare's adjusted EBITDA; (ii) ModivCare had insufficient liquidity; and (iii) defendants' positive statements about ModivCare's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against ModivCare. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by March 31, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] SOURCE: Rosen Law Firm Copyright Business Wire 2025. PUB: 03/28/2025 12:10 PM/DISC: 03/28/2025 12:10 PM
